Human performance monitoring (HPM) devices for sweat sensing in both civilian and military uses necessitate chemical sensors with low limits of detection, rapid read out times, and ultra-low volumes. Electronic and electrochemical sensing mechanisms for biomarker identification and quantification are attractive for overall ease of use, including robust, portable, fast readout, and simple operation. Transistors have the high signal gain required to sense low concentrations (µM to pM) at low volumes (µL to nL) in real-time (<1 minute), metrics not achievable by benchtop analytical techniques. Two main challenges currently prohibit the realization of transistor-based biosensors: i) the need for printed devices for low-cost, disposable sensors; and ii) the need to overcome diminished sensitivity in high ionic strength solutions. In this proof-of-concept work, we demonstrate organic electrochemical transistors (OECT) as a promising low cost, printable device platform for electrochemical detection of biomarkers in high ionic strength environments. This work focuses on how the materials choice and functionality impacts the electrochemical and sensor and transducer performance and determining the feasibility of reducing the size of the sensor to nanoliter volume detection. Initial studies target dopamine. Detection limits for simple electrochemical approaches using platinum or glassy carbon electrodes remain relatively high (~ 1-10 ng/mL or 50 nM). Using an OECT, we demonstrate an initial detection level of dopamine at ~ 10 pg/mL achieved without any selective binding modifications to the gate electrode at gate voltages below 1 V.
INTRODUCTION
Biological function is regulated by local concentrations of biomarkers including hormones, neurotransmitters, antibodies, and proteins. For example, catecholamines (dopamine, norepinephrine, and epinephrine) are a class of neurotransmitters and hormones involved in the regulation of the neurological, psychiatric, endocrine, and cardiovascular systems, [1] [2] [3] and potentially the modulation of immune responses. [4] [5] [6] Quantification plays a key role in the diagnosis and prognosis of disease, cellular functionality, and the development of new treatment methods. Specifically, dopaminergic systems influence memory, cognition, motor activity, neuroendocrine regulation, and pleasure/reward function, 7 whereas abnormalities are associated with disorders that affect movement (Parkinson's and Segawa disease), neuropsychiatric (depression, anxiety, addiction), and metabolic diseases. 2, 8, 9 Dopamine exists at low (nM to pM) concentrations in a number of biological fluids including urine, plasma, and blood. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Typical quantification approaches include radioimmunoassays 12, [20] [21] [22] and complex benchtop analytical methods such as fluorescence, [23] [24] [25] mass spectroscopy, and chromatography. 11, 13, [26] [27] [28] These approaches are limited with respect to portability, sample preparation, antibody availability, reaction/response times, and cost. Most critical is the need for low limits of detection (µM to pM concentrations) in small volumes (µL to nL) in real time (< 1 minute), ideally in situ to garner knowledge about biomarker behaviors in complex and/or unique environments, such as nerve synapses.
Electronic and electrochemical sensing mechanisms for biomarker identification and quantification are attractive for overall ease of use, including robust, portable, fast readout, and simple operation. Field-effect transistors (FET) offer the potential for miniaturization, multiplexing, and fast response time of biomarker quantification. [29] [30] [31] [32] [33] [34] A number of strategies have been employed for selective dopamine detection at the gate electrode including ion selective membranes, polymer coatings, nanovesicles, and G-protein-coupled receptors. [35] [36] [37] [38] State-of-the-art for dopamine detection arises from complementary metal-oxide-semiconductor (CMOS) FETs that demonstrated fM limits of detection in idealized laboratory settings. 39, 40 Despite these advances, FET-based bioanalytical devices have generally been limited to laboratory proof-of-concept studies. The fundamental measurement of transduction in a FET is to convert an ionic environment to an electrical signal via a reversible reaction. Yet the inorganic semiconductors used in FETs are asymmetric with respect to the electrolyte -ions do not enter the electronic readout device -a major materials limitation. This phase asymmetry leads to diminished sensitivity in ionic solutions and instability arising from electronic drift, leakage currents, and/or undesired chemical reactions. [41] [42] [43] [44] [45] [46] In contrast to FETs, organic electrochemical transistors (OECTs) consist of an organic semiconductor interfaced with an electrolyte, in which the gate electrode is immersed. OECT operation relies on ions that are transported in and out of the organic film, thereby altering its doping state and hence the conductivity. 47 This hybrid electrical-ionic conduction enables printable OECT bionsensors that operate at relatively low gate voltages (<1 V in aqueous environments) with higher signal amplification than FET counterparts. 48 Most attention in OECT development has focused on materials design within the source-drain channel to control the amplification characteristics of the device. [49] [50] [51] [52] [53] [54] Limited focus has been devoted to demonstrate of the OECT as an operating sensor. The goal of this project was to construct and test an organic semiconductor sensor devices using an organic electrochemical transistor (OECT) architecture with biomarker recognition of a single biomarker molecule on the sensor's gate surface. Our minimum requirement is to determine if a conductive polymer-based device can be used to electrochemically detect dopamine at varying concentrations (nanomolar to picomolar) and to test feasibility on miniaturization to approximately 1 nL, the volume of sweat emitted by a single pore.
MATERIALS AND METHODS
Initial proof-of-concept structures for laboratory-scale test experiments were prepared by spin-cast conductive polymers onto glass substrates coated with the transparent conductor indium tin oxide (ITO) as prepatterned source/drain electrode structures. Each substrate contains 5 pairs of interdigitated finger electrodes, where one side corresponds to the source contacts and the other one to the drain contacts. Polymer channels were comprised of poly(3-hexylthiophene) (P3HT) electrodes. To complement the transistor structure, the polymer films were contacted with a small amount of electrolyte (PBS, pH 7.4) confined in a polydimethylsiloxane (PDMS) well, and a metal wire was immersed into the electrolyte as gate electrode. For the electrical characterization, gate voltage and source/drain voltage were controlled using two Keithley 2400 sourcemeters, which also measured the resulting currents. A LabView program created by our group was used to automatically control the sourcemeters and record measurement data.
RESULTS AND DISCUSSION

Organic electrochemical transistor performance
This effort focused on turn-on channel conductivity devices, which will be most useful for sensing singnals at low concentration, as there is no background current. This also affords lower power consumption of the device. P3HT OECTs operate as accumlation-type transistors whereby the source/drain current is increased with increasing gate voltage above the threshold voltage. This current increase is due to electrochemical doping of the polymer under the influence of the applied gate voltage, which occurs along with intercalation of counter ions (here mainly Cl -) into the polymer film. In Fig. 1 , an appreciable source/drain current is observed for gate voltages of 0.8 V or higher. This required input voltage is small compared to the voltages of typically 50-100 V necessary to turn on solid state fieldeffect transistors-an important advantage of the organic electrochemical transistor. In the bottom panel, it can be readily observed that the polymer increases substantially in conductivity with increasing gate voltage at potentials above 0.6 V, with respect to the gate electrode.
Validity of miniaturization
Focusing on detection of sweat requires point-source detection to minimize biomarker degradation. Human sweat rates range from 0-.2 to >15 nL/pore/minute based on methacholine injection studies. To evaluate the feasibility of miniaturization towards nanoliter volumes, we focused on decreasing the channel lengths of the OECT polymer channels. Table 1 shows the relative sweat volume, droplet radius and the corresponding droplet footprint that would need to be encompassed by a particular sensor. To reach a target of 1 nL would require a detection area of 10 4 µm 2 , which for an OECT must include both the transistor channel and the gate electrode. 
Sweat Volume Droplet radius (µm) Droplet footprint (µm
)
1 mL ~7800 ~2x10 8 10 µL ~1600 ~9x10 6 1 µL ~ 780 ~2x10 6 1 nL ~78 ~2x10 4 1 pL ~7.8 ~2x10
To evaluate the feasibility of miniaturization towards nanoliter volume detection, we focused on decreasing the channel lengths of the OECT polymer channels. The channel width was held constant at 30 mm, and the channel length was varies from 50 to 150 µm. This results in a decrease down to sweat volume detections of ~ 1 µL volume droplet. The results are provided in Figure 2 . Multiple devices are included for statistics, represented by the black squares. We readily observed that shorter channel lengths necessary for smaller volumes of sweat lead to higher transconductance. The transconductance was also observed to scale via a volumetric effect, as shown by the fit provided. In other words, the transconductance (g) can readily be scaled by optimizing the ratio of the channel width (W), the channel length (L), and the polymer thickness (d), for a given charge carrier mobility (µ) and material capacitance (C*). This result is critical in the context of manufacturability, which must consider the cost and printability of relevant materials. 
Measurement of dopamine reaction rates at metal versus polymer gate electrodes.
In OECTs, materials choice plays a crucial role in the transduction of chemical to electrical signals. If a metallic gate electrode is used, the reaction rate of the biomarker at this metal will determine the potential drops at the metal/electrolyte interface and the electrolyte/polymer interface, and will thereby affect the polymer doping level and the resulting current signal. At the same time, it is important to know at what rate the biomarker might react at the polymer itself, because such a reaction may equally affect interfacial potential drops and output signal. The biomarker reaction rate at the polymer will have an even bigger influence in biosensors based on all-polymeric OECTs, in which the gate electrode is made of polymer instead of metal.
In view of this crucial role of reaction rates, we compared the kinetics of oxidation/reduction of the biomarker dopamine at a metal (Pt disk electrode) versus a polymer (a drop-cast film of PEDOT:PSS) using cyclic voltammetry. An example for a Pt disk electrode is shown in Figure 3 (top). In addition, the reaction was studied at a GC electrode, since GC is a common reference material in studies on electrochemical and electrocatalytic biosensing.
A parameter commonly used to assess electrode kinetics is the standard rate constant k 0 of the Butler-Volmer model, which corresponds to the rate constant of the electrode reaction at zero over-potential. Here, k 0 was estimated from the separation of the dopamine oxidation and reduction peaks in the cyclic voltammograms using Nicholson's method, see Figure 3 (bottom). 55 The largest value of k 0 was observed at the Pt electrode, indicating that oxidation of dopamine proceeded at the highest rate at this metal. Interestingly, k 0 of the reaction at the PEDOT:PSS film was about 2-3 times smaller, but comparable to that of the reaction at GC. These results serve as important input parameters in our ongoing simulations of the effect of reaction rates on biomarker capture efficiency in OECT biosensors. 
OECT tests in the presence of dopamine
Detection of biomarkers in an OECT is based upon changes in the distribution of the electric field between gate electrode and polymer that result from electrochemical reaction of the biomarker at the gate. To test the response of our laboratory-scale test structures to the presence of dopamine, we measured the output characteristics of P3HT OECTs in contact with electrolytes containing varied concentrations of the biomarker. Fig. 4 (left) shows the transfer curves of an OECT with (1) pure PBS and (2) PBS with 70 µM dopamine as electrolyte. In the presence of dopamine, the source/drain current at a given gate voltage Vg tended to be lower than in the absence of the biomarker. Upon addition of dopamine at varied concentrations at a gate voltage of 0.7 V (Figure 4, right) , the source/drain current showed a response to concentrations as little as 0.1 nM (see inset of figure), indicating a very low limit of detection to at least 0.1 nM of dopamine. The variation of the current with the dopamine concentration (on the semi-logarithmic scale) showed a linear behavior up to a concentration of 100 nM. At higher concentrations, the trend deviates, suggesting more complex reaction chemistries and/or sticking of the biomarker to the polymer channel. Based on these results, OECTs based on P3HT show promise for application as dopamine sensors even in the absence of a selective bio-recognition element. If time allows, future work will consider the further concentration range of dopamine. We expect that at a sufficiently low concentration, we will no longer see a change in response, which will define the limit of detection. 
CONCLUSIONS
Human performance monitoring (HPM) devices for sweat sensing in both civilian and military uses necessitate chemical sensors with low limits of detection, rapid read out times, and ultra-low volumes. Electronic and electrochemical sensing mechanisms for biomarker identification and quantification are attractive for overall ease of use, including robust, portable, fast readout, and simple operation. In this proof-of-concept work, we demonstrate organic electrochemical transistors (OECT) as a promising low cost, printable device platform for electrochemical detection of biomarkers in high ionic strength environments. Herein we have demonstrated the predictability and scalability of OECTs for miniaturization towards nanoliter volume sampling. Additionally we demonstrated an initial detection level of dopamine at ~ 10 pg/mL achieved without any selective binding modifications to the gate electrode at gate voltages below 1 V. 
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